[口試公告] 112-2碩士學位論文口試
| 學生姓名 | 口試時間 | 論文題目 |
| 許忠雄 HSU, CHUNG HSIUNG |
2024/07/18 | 泌尿道上皮癌病人的抗生素使用對免疫檢查點抑制劑療效影響的關聯性 Association between Antibiotic Treatment and The Efficacy of Immune Checkpoint Inhibitors in Urothelial Carcinoma |
| 簡新融 CHIEN, HSIN-JUNG |
2024/07/16 | C端烷基化T7胜肽的組裝研究 Assemble Study of C-alkylated T7 Peptides |
| 呂貞慧 LU, MARIE JEN-HUEY |
2024/07/16 | 慢性阻塞性肺病病人呼吸道急性惡化風險之性別差異：一項以族群為基礎的世代研究 Sex differences in the risk of exacerbations among patients with chronic obstructive pulmonary disease: a population-based cohort study |
| 邱咸智 CHIU, HSIEN-CHIH |
2024/07/12 | 急性失代償性心衰竭患者環利尿劑併用Thiazides的療效與安全性 Comparing the Effectiveness and Safety of Combining Thiazide Diuretics with Monotherapy Intravenous Loop Diuretics in Acute Decompensated Heart Failure Patients |
| 鄭詠馨 TA, YONG XIN |
2024/07/12 | 蒲公英狀奈米載體結合具標靶性適配體以達到胰臟癌化學免疫療法的效果 Dandelion-like nanoparticles with aptamer-targeted function for chemoimmunotherapeutic strategies in pancreatic cancer |
| 林家禾 LIN, CHIA HO |
2024/07/11 | 帕金森氏症患者使用高血壓藥物跟姿態性低血壓的關係：單中心巢式病例對照研究 Relationship between the Use of Antihypertensive Agents and Orthostatic Hypotension in Patients with Parkinson’s Disease: A Single-Centered, Nested Case-Control Study |
| 易恩頡 YI, EN-CHIEH |
2024/07/10 | 偏頭痛病人血球數值及頭痛嚴重程度和預防性用藥評估探討 Evaluation of the Correlation in Hematological Parameters, Severity of Migraine and Effectiveness of Migraine Prophylactic Therapies |
| 洪同穎 HUNG, TUNG-YING |
2024/07/09 | 評估二肽基肽酶-4抑制劑對第二型糖尿病合併晚期慢性腎臟病患者發生腎臟相關不良事件之風險關聯性 Assessment of Renal Risks Associated with Dipeptidyl Peptidase-4 Inhibitors among Type 2 Diabetic Patients with Advanced Chronic Kidney Disease |
| 廖旭晨 LIAO, HSU-CHEN |
2024/07/05 | 非小細胞肺癌患者使用ALK抑制劑所致心毒性之風險探討 Investigation of the Risk of Cardiotoxicity Associated with ALK Inhibitors in Non-Small Cell Lung Cancer Patients |
| 蘇庭弘 SU, TING-HONG |
2024/07/04 | 桂花之化學成分及生物活性之研究 Studies on the Main Chemical Constituents and Biological Activities of the Flowers of Osmanthus fragrans |
| 張育瑄 CHANG, YU-HSUAN |
2024/07/04 | 台灣產桑椹之化學成分及生物活性之研究 Studies on the Main Chemical Components and their Biological Activities of the Fruits of Taiwanese Morus alba L. |
| 詹子寬 CHAN, TZU-KUAN |
2024/07/03 | SGLT2抑制劑與GLP-1受體促效劑用於糖尿病病人心肌梗塞後預後之影響 The Clinical Benefits of SGLT2i and GLP-1RA on Post-myocardial Infarction in Diabetic Patients |
| 李柏宏 LEE, PO HUNG |
2024/6/27 | 以台灣醫師、法規管理與健康保險人員及學者專家之觀點探討生物相似性藥品可交換使用管理方式之態度 Attitudes toward approaches to interchangeability of biosimilars: Perspectives from prescribers, regulators, and experts in Taiwan |
| 詹書華 CHAN, SHU-HUA |
2024/6/13 | 台灣擴散期小細胞肺癌病人使用第一線療法免疫檢查點抑制劑Durvalumab或Atezolizumab合併化學治療或單用化學治療之成本效果分析 Cost-Effectiveness Analysis of Durvalumab and Atezolizumab Immunochemotherapies Versus Chemotherapy Alone as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer in Taiwan |
| 魏婕安 WEI, CHIEH-AN |
2024/6/11 | 從實驗室內部的小分子化合物資料庫中探索用於治療癌症的潛 Exploring the potential drug candidates from in-house small molecules compound library for cancer treatment |
~ 2024/7/8更新